FMR LLC

Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.

CIK 315066 BOSTON, MA

Position in CRBP

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$6,460

-$2,730 QoQ

Shares Held

688

-39.1% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 32.70348837209303.ToString("F0")% Shared 0.ToString("F0")% None 67.29651162790698.ToString("F0")%

Healthcare · as of Mar 31, 2026

FMR LLC holds $49,683,576,696 across 351 Biotechnology names. CRBP ranks #307 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	14,579,166	$4,823,808,652
2	ARGX	Argenx SE	4,991,034	$3,644,702,577
3	MRNA	Moderna, Inc.	45,672,024	$2,320,138,818
4	ROIV	Roivant Sciences Ltd.	77,981,253	$2,160,080,705
5	INSM	INSMED Inc	13,160,167	$2,151,950,504
6	IONS	Ionis Pharmaceuticals Inc	24,556,637	$1,843,957,869
7	RPRX	Royalty Pharma plc	25,152,242	$1,206,553,046
8	REGN	Regeneron Pharmaceuticals, Inc.	1,518,192	$1,173,015,865

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,460	688	-39.1%	Shares	Defined	2026-05-15
2025-12-31	$9,190	1,129	-19.4%	Shares	Defined	2026-02-17
2025-09-30	$17,710	1,400	-3.8%	Shares	Defined	2025-11-13
2025-06-30	$10,038	1,455	-56.8%	Shares	Defined	2025-08-14
2025-03-31	$17,900	3,371	+2117.8%	Shares	Defined	2025-05-12
2024-12-31	$1,793	152	-98.5%	Shares	Defined	2025-02-13
2024-09-30	$206,877	10,028	+33.0%	Shares	Defined	2024-11-13
2024-06-30	$341,275	7,542	-17.6%	Shares	Defined	2024-08-13
2024-03-31	$359,202	9,154	+173.0%	Shares	Defined	2024-05-13
2023-12-31	$20,252	3,353	0.0%	Shares	Defined	2024-02-13
2023-09-30	$22,599	3,353	0.0%	Shares	Defined	2023-11-13
2023-06-30	$26,287	3,353	-0.4%	Shares	Defined	2023-08-11
2023-03-31	$24,463	3,365	—	Shares	Defined	2023-08-11
No filing history on record for this holder in this stock.